May 26, 2023
May 26, 2023 - Lexicon Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration
(FDA) has approved InpefaTM (sotagliflozin), a once-daily oral tablet to reduce
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
May 25, 2023
May 25, 2023 - Pfizer Inc. announced that the U.S. Food and Drug Administration approved PaxlovidTM (nirmatrelvir tablets and ritonavir tablets) for the treatment of
May 24, 2023
May 24, 2023 - Celltrion USA has announced that the U.S. Food and Drug Administration (FDA) has approved Yuflyma ® (adalimumab-aaty), a high-concentration (100mg/mL) and
May 23, 2023
May 23, 2023 – Braeburn Inc. has announced that the U.S. Food and Drug Administration (FDA) has
approved Brixadi (buprenorphine) extended-release injection
May 23, 2023
May 23, 2023 - Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. has announced that the U.S.
Food and Drug Administration (FDA)
May 22, 2023
May 22, 2023 - Indivior PLC has announced that the U.S. Food and Drug Administration (FDA) approved Opvee ® (nalmefene) nasal spray for the emergency treatment
May 22, 2023
May 22, 2023 - Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the Cyltezo ® Pen, a new autoinjector option for Cyltezo
May 19, 2023
May 19, 2023 – AbbVie has announced that the U.S. Food and Drug Administration approved Epkinly
(epcoritamab-bysp) injection, a treatment for adult patients with relapsed